| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |